Filed: 5/15/2024ACC: 0001855655-24-000005
📋 What this filing means
PARADIGM BIOCAPITAL ADVISORS LP filed this quarterly 13F‑HR report disclosing 34 equity positions with a total reported market value of $2.84B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
34
Positions
$2.84B
Total AUM (reported)
84.27M
Total Shares
Allocation by class
COM$1.88B66.3%
SPONSORED ADR$294.17M10.4%
COMMON STOCK$265.55M9.3%
SPONSORED ADS$211.91M7.5%
ADS$116.17M4.1%
SPON ADS$41.00M1.4%
SHS$29.63M1.0%
Portfolio Concentration
Top 3$796.64M28.0%
4–10$876.92M30.9%
11–25$1.04B36.8%
Rest$122.40M4.3%
Top 3 weight
28.0%
Top 10 weight
58.9%
Voting Authority Distribution
Total shares with voting rights: 84.27M
Sole
Full voting authority
84.27M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole34
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings34
Rows:
NUVALENT INC
SOLEShares4.18M
TypeSH
Market value$313.71M
11.04%
Sole
4.18M
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares3.82M
TypeSH
Market value$265.55M
9.35%
Sole
3.82M
Shared
0.00
None
0.00
ARGENX SE
SOLEShares552.12K
TypeSH
Market value$217.38M
7.65%
Sole
552.12K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares2.39M
TypeSH
Market value$148.80M
5.24%
Sole
2.39M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares3.12M
TypeSH
Market value$146.27M
5.15%
Sole
3.12M
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares1.08M
TypeSH
Market value$139.60M
4.91%
Sole
1.08M
Shared
0.00
None
0.00
IMMUNOCORE HLDGS PLC
SOLEShares1.79M
TypeSH
Market value$116.17M
4.09%
Sole
1.79M
Shared
0.00
None
0.00
LEGEND BIOTECH CORP
SOLEShares1.98M
TypeSH
Market value$111.17M
3.91%
Sole
1.98M
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares2.61M
TypeSH
Market value$107.94M
3.80%
Sole
2.61M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares2.48M
TypeSH
Market value$106.97M
3.77%
Sole
2.48M
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
SOLEShares2.86M
TypeSH
Market value$104.08M
3.66%
Sole
2.86M
Shared
0.00
None
0.00
CEREVEL THERAPEUTICS HLDNG I
SOLEShares2.33M
TypeSH
Market value$98.51M
3.47%
Sole
2.33M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares2.91M
TypeSH
Market value$93.95M
3.31%
Sole
2.91M
Shared
0.00
None
0.00
OLEMA PHARMACEUTICALS INC
SOLEShares7.90M
TypeSH
Market value$89.47M
3.15%
Sole
7.90M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares5.03M
TypeSH
Market value$88.10M
3.10%
Sole
5.03M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares1.24M
TypeSH
Market value$84.70M
2.98%
Sole
1.24M
Shared
0.00
None
0.00
ALPINE IMMUNE SCIENCES INC
SOLEShares2.12M
TypeSH
Market value$84.08M
2.96%
Sole
2.12M
Shared
0.00
None
0.00
BICYCLE THERAPEUTICS PLC
SOLEShares3.25M
TypeSH
Market value$80.84M
2.85%
Sole
3.25M
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares507.95K
TypeSH
Market value$76.79M
2.70%
Sole
507.95K
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares3.14M
TypeSH
Market value$66.88M
2.35%
Sole
3.14M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares2.45M
TypeSH
Market value$44.62M
1.57%
Sole
2.45M
Shared
0.00
None
0.00
AUTOLUS THERAPEUTICS PLC
SOLEShares6.43M
TypeSH
Market value$41.00M
1.44%
Sole
6.43M
Shared
0.00
None
0.00
Y-MABS THERAPEUTICS INC
SOLEShares2.23M
TypeSH
Market value$36.32M
1.28%
Sole
2.23M
Shared
0.00
None
0.00
IMMATICS N.V
SOLEShares2.82M
TypeSH
Market value$29.63M
1.04%
Sole
2.82M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares799.05K
TypeSH
Market value$25.82M
0.91%
Sole
799.05K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NUVALENT INCSOLE | COM | 4.18M | SH | $313.71M 11.04% | 4.18M | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 3.82M | SH | $265.55M 9.35% | 3.82M | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 552.12K | SH | $217.38M 7.65% | 552.12K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 2.39M | SH | $148.80M 5.24% | 2.39M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 3.12M | SH | $146.27M 5.15% | 3.12M | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 1.08M | SH | $139.60M 4.91% | 1.08M | 0.00 | 0.00 |
IMMUNOCORE HLDGS PLCSOLE | ADS | 1.79M | SH | $116.17M 4.09% | 1.79M | 0.00 | 0.00 |
LEGEND BIOTECH CORPSOLE | SPONSORED ADS | 1.98M | SH | $111.17M 3.91% | 1.98M | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 2.61M | SH | $107.94M 3.80% | 2.61M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 2.48M | SH | $106.97M 3.77% | 2.48M | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCSOLE | COM | 2.86M | SH | $104.08M 3.66% | 2.86M | 0.00 | 0.00 |
CEREVEL THERAPEUTICS HLDNG ISOLE | COM | 2.33M | SH | $98.51M 3.47% | 2.33M | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 2.91M | SH | $93.95M 3.31% | 2.91M | 0.00 | 0.00 |
OLEMA PHARMACEUTICALS INCSOLE | COM | 7.90M | SH | $89.47M 3.15% | 7.90M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 5.03M | SH | $88.10M 3.10% | 5.03M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 1.24M | SH | $84.70M 2.98% | 1.24M | 0.00 | 0.00 |
ALPINE IMMUNE SCIENCES INCSOLE | COM | 2.12M | SH | $84.08M 2.96% | 2.12M | 0.00 | 0.00 |
BICYCLE THERAPEUTICS PLCSOLE | SPONSORED ADS | 3.25M | SH | $80.84M 2.85% | 3.25M | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 507.95K | SH | $76.79M 2.70% | 507.95K | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 3.14M | SH | $66.88M 2.35% | 3.14M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 2.45M | SH | $44.62M 1.57% | 2.45M | 0.00 | 0.00 |
AUTOLUS THERAPEUTICS PLCSOLE | SPON ADS | 6.43M | SH | $41.00M 1.44% | 6.43M | 0.00 | 0.00 |
Y-MABS THERAPEUTICS INCSOLE | COM | 2.23M | SH | $36.32M 1.28% | 2.23M | 0.00 | 0.00 |
IMMATICS N.VSOLE | SHS | 2.82M | SH | $29.63M 1.04% | 2.82M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 799.05K | SH | $25.82M 0.91% | 799.05K | 0.00 | 0.00 |
Page 1 of 2